Follow
Yi Zhu
Yi Zhu
Assistant Professor, Mayo Clinic
Verified email at mayo.edu - Homepage
Title
Cited by
Cited by
Year
The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
Y Zhu, T Tchkonia, T Pirtskhalava, AC Gower, H Ding, N Giorgadze, ...
Aging cell 14 (4), 644-658, 2015
19912015
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
T Tchkonia, Y Zhu, J Van Deursen, J Campisi, JL Kirkland
The Journal of clinical investigation 123 (3), 966-972, 2013
17172013
Cellular senescence mediates fibrotic pulmonary disease
MJ Schafer, TA White, K Iijima, AJ Haak, G Ligresti, EJ Atkinson, AL Oberg, ...
Nature communications 8, 14532, 2017
12242017
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Y Zhu, T Tchkonia, H Fuhrmann‐Stroissnigg, HM Dai, YY Ling, MB Stout, ...
Aging cell 15 (3), 428-435, 2016
9282016
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease (vol 47, pg 446 …
LJ Hickson, LGP Prata, SA Bobart, TK Evans, N Giorgadze, SK Hashmi, ...
EBIOMEDICINE 52, 2020
830*2020
Mechanisms and metabolic implications of regional differences among fat depots
T Tchkonia, T Thomou, Y Zhu, I Karagiannides, C Pothoulakis, ...
Cell metabolism 17 (5), 644-656, 2013
7532013
Fisetin is a senotherapeutic that extends health and lifespan
MJ Yousefzadeh, Y Zhu, SJ McGowan, L Angelini, ...
EBioMedicine 36, 18-28, 2018
6732018
Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
CM Roos, B Zhang, AK Palmer, MB Ogrodnik, T Pirtskhalava, NM Thalji, ...
Aging Cell 15 (5), 973-977, 2016
6722016
Identification of HSP90 inhibitors as a novel class of senolytics
H Fuhrmann-Stroissnigg, YY Ling, J Zhao, SJ McGowan, Y Zhu, ...
Nature communications 8 (1), 422, 2017
5842017
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Y Zhu, EJ Doornebal, T Pirtskhalava, N Giorgadze, M Wentworth, ...
Aging (Albany NY) 9 (3), 955, 2017
5782017
The clinical potential of senolytic drugs
JL Kirkland, T Tchkonia, Y Zhu, LJ Niedernhofer, PD Robbins
Journal of the American Geriatrics Society 65 (10), 2297-2301, 2017
5312017
Targeting senescent cells alleviates obesity‐induced metabolic dysfunction
AK Palmer, M Xu, Y Zhu, T Pirtskhalava, MM Weivoda, CM Hachfeld, ...
Aging cell 18 (3), e12950, 2019
4532019
An aged immune system drives senescence and ageing of solid organs
MJ Yousefzadeh, RR Flores, Y Zhu, ZC Schmiechen, RW Brooks, ...
Nature 594 (7861), 100-105, 2021
4402021
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
M Ogrodnik, Y Zhu, LGP Langhi, T Tchkonia, P Krüger, E Fielder, ...
Cell Metabolism, 2019
4102019
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases
Y Zhu, JL Armstrong, T Tchkonia, JL Kirkland
Current Opinion in Clinical Nutrition & Metabolic Care 17 (4), 324-328, 2014
2802014
Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
M Ogrodnik, SA Evans, E Fielder, S Victorelli, P Kruger, H Salmonowicz, ...
Aging Cell 20 (2), e13296, 2021
2172021
Senolytics reduce coronavirus-related mortality in old mice
CD Camell, MJ Yousefzadeh, Y Zhu, LGPL Prata, MA Huggins, M Pierson, ...
Science, 2021
2122021
The senescence-associated secretome as an indicator of age and medical risk
MJ Schafer, X Zhang, A Kumar, EJ Atkinson, Y Zhu, S Jachim, DL Mazula, ...
JCI insight 5 (12), 2020
2082020
Cellular senescence: a key therapeutic target in aging and diseases
L Zhang, LE Pitcher, MJ Yousefzadeh, LJ Niedernhofer, PD Robbins, ...
The Journal of Clinical Investigation 132 (15), 2022
1392022
Discovery, development, and future application of senolytics: theories and predictions
EO Wissler Gerdes, Y Zhu, T Tchkonia, JL Kirkland
The FEBS journal 287 (12), 2418-2427, 2020
1282020
The system can't perform the operation now. Try again later.
Articles 1–20